These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 33184044)

  • 1. Diabetic ketoacidosis with SGLT2 inhibitors.
    Musso G; Saba F; Cassader M; Gambino R
    BMJ; 2020 Nov; 371():m4147. PubMed ID: 33184044
    [No Abstract]   [Full Text] [Related]  

  • 2. Sodium-glucose co-transporter 2 inhibitors in the peri-operative period: A warning to all clinicians.
    Waylen AL; Riedel B
    BJU Int; 2019 May; 123 Suppl 5():6-7. PubMed ID: 31116003
    [No Abstract]   [Full Text] [Related]  

  • 3. Ketoacidosis Due to Empagliflozin, a Paradigm Shift: Case Report and Review of Literature.
    Hernandez-Quiles C; Ramirez-Duque N; Acosta-Delgado D
    Curr Diabetes Rev; 2019; 15(4):259-262. PubMed ID: 30047331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Diabetic Ketoacidosis after Initiation of an SGLT2 Inhibitor.
    Fralick M; Schneeweiss S; Patorno E
    N Engl J Med; 2017 Jun; 376(23):2300-2302. PubMed ID: 28591538
    [No Abstract]   [Full Text] [Related]  

  • 5. Possible association between diabetic ketoacidosis and use of sodium-glucose co-transporter 2 inhibitor in a 17-year-old youth with type 2 diabetes.
    Shamchuk A; Doulla M; Jetha M
    CMAJ; 2021 Sep; 193(35):E1385-E1388. PubMed ID: 34493565
    [No Abstract]   [Full Text] [Related]  

  • 6. SGLT2 inhibitors increase risk for diabetic ketoacidosis in type 2 diabetes.
    Griffin TP; Dinneen SF
    Ann Intern Med; 2020 Oct; 173(8):JC40. PubMed ID: 33075260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In type 2 diabetes, SGLT2 inhibitors were linked to diabetic ketoacidosis vs. DPP-4 inhibitors.
    Liakos A; Tsapas A; Bekiari E
    Ann Intern Med; 2020 Dec; 173(12):JC70. PubMed ID: 33316195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two alcoholic liver cirrhosis patients developed diabetic ketoacidosis after SGLT2 inhibitors-prescription.
    Chao HY; Kornelius E
    J Formos Med Assoc; 2020 Dec; 119(12):1886-1887. PubMed ID: 32690358
    [No Abstract]   [Full Text] [Related]  

  • 9. Fournier's Gangrene and Diabetic Ketoacidosis Associated with Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: Life-Threatening Complications.
    Kasbawala K; Stamatiades GA; Majumdar SK
    Am J Case Rep; 2020 Jun; 21():e921536. PubMed ID: 32483108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SGLT2 Inhibitors and Euglycemic Ketoacidosis.
    Masuta P; Johri G; Paul M
    Am J Ther; 2018; 25(4):e498-e500. PubMed ID: 28537992
    [No Abstract]   [Full Text] [Related]  

  • 11. Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis.
    Hamblin PS; Wong R; Bach LA
    Med J Aust; 2021 Feb; 214(2):94-94.e1. PubMed ID: 33349919
    [No Abstract]   [Full Text] [Related]  

  • 12. Sodium-glucose cotransporter type 2 inhibitors: managing the small but critical risk of diabetic ketoacidosis.
    Meyer EJ; Thiruvenkatarajan V; Jesudason D
    Med J Aust; 2021 Feb; 214(2):93-93.e1. PubMed ID: 33349926
    [No Abstract]   [Full Text] [Related]  

  • 13. Lessons from the bedside: ketoacidosis and SGLT2 inhibitors.
    Chow YY; Worsley R; Topliss DJ
    Med J Aust; 2016 Aug; 205(4):191-2. PubMed ID: 27510353
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic ketoacidosis precipitated by therapy with antidiabetic agents SGLT2 inhibitors: two cases.
    Venkatesh B; Moore G; Gill D; Kelly W
    Crit Care Resusc; 2015 Dec; 17(4):280-2. PubMed ID: 26640065
    [No Abstract]   [Full Text] [Related]  

  • 15. Insights Into the Recognition and Management of SGLT2-Inhibitor-Associated Ketoacidosis: It's Not Just Euglycemic Diabetic Ketoacidosis.
    Dizon S; Keely EJ; Malcolm J; Arnaout A
    Can J Diabetes; 2017 Oct; 41(5):499-503. PubMed ID: 28797889
    [No Abstract]   [Full Text] [Related]  

  • 16. Beware Ketoacidosis with SGLT2 Inhibitors in Latent Autoimmune Diabetes of the Adult.
    Nolan BJ; Varadarajan S; Fourlanos S; Neoh SL
    Am J Med; 2020 Aug; 133(8):e422-e424. PubMed ID: 31923401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Euglycemic diabetic ketoacidosis associated with the use of a sodium-glucose cotransporter-2 inhibitor.
    Zhang L; Tamilia M
    CMAJ; 2018 Jun; 190(25):E766-E768. PubMed ID: 29941433
    [No Abstract]   [Full Text] [Related]  

  • 18. A potential diagnostic problem on the ICU: Euglycaemic diabetic Ketoacidosis associated with SGLT2 inhibition.
    Sanusi I; Sarnowski A; Russell-Jones D; Forni LG
    J Crit Care; 2020 Jun; 57():19-22. PubMed ID: 32007835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SGLT2 Inhibitors and Ketoacidosis: Cause for Concern?
    Abate N; Chandalia M
    Metab Syndr Relat Disord; 2016 Feb; 14(1):1-2. PubMed ID: 26554527
    [No Abstract]   [Full Text] [Related]  

  • 20. Perioperative euglycemic diabetic ketoacidosis following use of SGLT-2 inhibitors after cardiac surgery.
    Pontes JPJ; de Melo CS; Arantes FBB; de Souza Ramos JTG; Módolo NSP; Navarro E Lima LH
    J Clin Anesth; 2021 Aug; 71():110201. PubMed ID: 33647525
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.